March 24, 2020
CEL-SCI Announces Bought Deal Offering
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced today that it has entered…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Cel-Sci
March 15, 2020
How do pharmaceutical companies profit from COVID-19? (do they?)
How do pharmaceutical companies prophet from COVID-19? Do they make the profit?
October 15, 2019
CEL-SCI Reports Recent Data Review by the Independent Data Monitoring Committee for Its Pivotal Phase 3 Head and Neck Cancer Study
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) announced today that the Independent Data Monitoring Committee (IDMC) for the Company’s pivotal…